Table of Contents Author Guidelines Submit a Manuscript
Journal of Sexually Transmitted Diseases
Volume 2015 (2015), Article ID 835261, 8 pages
http://dx.doi.org/10.1155/2015/835261
Research Article

External Quality Assessment for the Detection of Chlamydia trachomatis in Urine Using Molecular Techniques in Belgium

Quality of Medical Laboratories, Scientific Institute of Public Health, J. Wytsman 14, 1050 Brussels, Belgium

Received 27 March 2015; Accepted 9 June 2015

Academic Editor: Aruna Singh Mittal

Copyright © 2015 Bernard China and Kris Vernelen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Gerbase, J. T. Rowley, D. H. L. Heymann, S. F. B. Berkley, and P. Piot, “Global prevalence and incidence estimates of selected curable STDS,” Sexually Transmitted Infections, vol. 74, supplement 1, pp. S12–S16, 1998. View at Google Scholar · View at Scopus
  2. W. C. Miller, C. A. Ford, M. Morris et al., “Prevalence of chlamydial and gonococcal infections among young adults in the United States,” Journal of the American Medical Association, vol. 291, no. 18, pp. 2229–2236, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Ducoffre, Surveillance des maladies infectieuses par un réseau de laboratoires de microbiologie, Institut Scientifique de Santé Publique, 2010, https://www.wiv-isp.be/epidemio/epifr/plabfr/plabanfr/10_035f_v.pdf.
  4. C. Gaydos and A. Essig, Chlamydiaceae in Manual of Clinical Microbiology, edited by: J. Versalovic, ASM Press, Washington, DC, USA, 10th edition, 2011.
  5. A. Nunes, P. J. Nogueira, M. J. Borrego, and J. P. Gomes, “Chlamydia trachomatis diversity viewed as a tissue-specific coevolutionary arms race,” Genome Biology, vol. 9, no. 10, article R153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Schachter and A. O. Osoba, “Lymphogranuloma venereum,” British Medical Bulletin, vol. 39, no. 2, pp. 151–154, 1983. View at Google Scholar · View at Scopus
  7. T. Ripa and P. A. Nilsson, “A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests,” Sexually Transmitted Diseases, vol. 34, no. 5, pp. 255–256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Onkelinx, “SPF Sécurité sociale. Arrêté royal du 19 mars 2008 modifiant l’annexe de l’arrêté royal du 14 septembre 1984 établissant la nomenclature des prestations de santé en matière d’assurance obligatoire soins de santé et indemnités,” Moniteur Belge, 18.04, pp.20982–20985, 2008.
  9. International Organization for Standardization, ISO 15189: Specifies Requirements for Quality and Competence Particular to Medical Laboratories, International Organization for Standardization, Geneva, Switzerland, 2007.
  10. International Organization for Standardization, ISO 17043 Conformity Assessment—General Requirements for Proficiency Testing, International Organization for Standardization, Geneva, Switzerland, 2010.
  11. T. Ripa, P. Nilsson, and T. Ripa, “A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests,” Eurosurveillance, vol. 11, no. 11, Article ID E061109.2, 2006. View at Google Scholar
  12. R. Demotte, “Ministères des affaires sociales et de la santé publique. Arrêté royal du 3 décembre 1999 relatif à l’agrément des laboratoires de biologie clinique par le Ministre qui a la santé publique dans ses attributions,” Moniteur Belge, no. 254, pp. 50217–50231, 1999. View at Google Scholar
  13. B. China, External Quality Assessment in Molecular Microbiology, Annual Report 2008, Service Public Fédéral Santé Publique, Sécurité de la Chaine Alimentaire et Environnement, Institut Scientifique de Santé Publique et Commission de Biologie Clinique, Bruxelles, Belgium, 2009, https://www.wiv-isp.be/QML/activities/external_quality/rapports/_down/BioMol_Microbiologie_art_24_et_24_bis/2008/7_RA.pdf.
  14. M. Klint, R. Hadad, L. Christerson et al., “Prevalence trends in Sweden for the new variant of Chlamydia trachomatis,” Clinical Microbiology and Infection, vol. 17, no. 5, pp. 683–689, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. U. Reischl, E. Straube, and M. Unemo, “The Swedish new variant of Chlamydia trachomatis (nvCT) remains undetected by many European laboratories as revealed in the recent PCR/NAT ring trial organised by INSTAND e.V., Germany,” Eurosurveillance, vol. 14, Article ID 19302, 2009. View at Google Scholar
  16. M. Unemo and I. N. Clarke, “The Swedish new variant of Chlamydia trachomatis,” Current Opinion in Infectious Diseases, vol. 24, no. 1, pp. 62–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Fieser, U. Simnacher, Y. Tausch et al., “Chlamydia trachomatis prevalence, genotype distribution and identification of the new Swedish variant in Southern Germany,” Infection, vol. 41, no. 1, pp. 159–166, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Piñeiro, M. Unemo, and G. Cilla, “Absence of Swedish new variant Chlamydia trachomatis (nvCT) and C. trachomatis genotype distribution in Gipuzkoa, Spain, 2009–2010,” Acta Dermato-Venereologica, vol. 92, no. 2, pp. 185–186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Won, P. Ramachandran, R. Steece et al., “Is there evidence of the new variant chlamydia trachomatis in the United States?” Sexually Transmitted Diseases, vol. 40, no. 5, pp. 352–353, 2013. View at Publisher · View at Google Scholar · View at Scopus